Ilaris 150 MG/ML vialml
Ended Awarded
- Contract number
- SPE2DB25FUFSZ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,483
Award facts
- Contract value 100% obligated
- $38,482.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at approximately $38.5K by the Defense Logistics Agency (DLA) on August 4, 2025, for the supply of ILARIS 150 mg/ml vials. The delivery order carries an ultimate completion date of August 25, 2025, and represents a single-award contract with no set-aside designation applied. This award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $500M vehicle valid through November 2026 that authorizes firm fixed-price delivery orders for comprehensive pharmaceutical products supporting military health facilities worldwide.
ILARIS is a specialty biologic pharmaceutical product used primarily in the treatment of inflammatory conditions, and this delivery order demonstrates DMS Pharmaceutical Group's continued role as a critical supplier within the federal pharmaceutical supply chain. The company's positioning as a primary distributor to Department of Defense healthcare sites reflects its established capability to deliver specialized medications and medical supplies efficiently to military health facilities. With consistent contract awards from the DLA covering diverse pharmaceutical products ranging from prescription medications to biologics and specialty injectables, DMS Pharmaceutical Group continues to serve as a key logistics partner for federal government healthcare procurement requirements.
Quick answers
Who was awarded contract SPE2DB25FUFSZ?
SPE2DB25FUFSZ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 4, 2025.
How much is contract SPE2DB25FUFSZ worth?
The government has obligated $38,483 on SPE2DB25FUFSZ.
Is contract SPE2DB25FUFSZ an order under another contract?
Yes. SPE2DB25FUFSZ is a delivery order under SPE2DB25D9363, an indefinite delivery contract.
Was contract SPE2DB25FUFSZ competed?
The extent of competition for SPE2DB25FUFSZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award